bpc-157 kidney BioAge Targets Inflammation, ㅤ, BioAge dosed the first patient in its Phase 2 QUELL-CV trial of BGE-102, an oral drug targeting the NLRP3 inflammasome to reduce chronic inflammation linked to aging. I highly recommend @inhypesanctuary ❤️

Suspected adverse reactions should be reported to the MHRA via the Yellow Card Scheme (yellowcard.mhra.gov.uk)

Purity & Quality The BPC-157 & TB-500 Blend supplied by NewBioRx is produced using controlled solid-phase peptide synthesis (SPPS), followed by purification through high-performance liquid chromatography (HPLC) to isolate the target peptide sequences and remove synthesis byproducts or truncated fragments

Improved muscle recovery and reduced downtime: Faster cellular repair translates to quicker return-to-function following muscle injury or intense training

If youre feeling nervous or just want some company, youre welcome to bring a friend or family member

Services & Pricing* 100% absorption Most IVs take 4560 min Medically supervised HSA & FSA eligible *Prices vary by location IV therapy in St Louis Ladue, MO delivers nutrients directly into the bloodstream for efficient nutrient delivery

Under medical supervision, treatment plans are tailored to each patients health goals, whether the focus is healthy aging, improved sleep quality, recovery, or overall vitality